Head-to-head comparisons of medication uses, side effects, warnings, and more.
Uptravi (selexipag) and Adempas (riociguat) are both medications used to treat pulmonary arterial hypertension (PAH), but they have some key differences. Uptravi is a prostacyclin agonist that works by relaxing the blood vessels in your lungs, and it is taken twice a day either orally or through an IV. In contrast, Adempas is a soluble guanylate cyclase (sGC) stimulator that also relaxes blood vessels but is taken every 8 hours and is only available in tablet form. Adempas is also used to treat chronic thromboembolic pulmonary hypertension (CTEPH), while Uptravi is not. Adempas has a significant risk of causing severe harm to unborn babies, so it is only available to females through a special REMS program, whereas Uptravi does not have this restriction. Common side effects for Uptravi include headache, diarrhea, and nausea, while Adempas also commonly causes a headache as well as indigestion, and dizziness. Additionally, Adempas can cause severe bleeding and dangerously low blood pressure, which are less common with Uptravi.
Uptravi (selexipag) is a prostacyclin agonist that's used in adults to treat pulmonary arterial hypertension (PAH), which is high blood pressure in the lungs. This medication can help prevent PAH from getting worse and lower the risk for hospitalization. Uptravi (selexipag) is a tablet that's taken by mouth twice per day. It's also available as an intravenous (IV) injection for people who can't take the medication by mouth. The most common side effects include headache, diarrhea, and nausea.
Adempas (riociguat) is a medication used to treat adults with pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH), both of which are types of high blood pressure in the lungs. It's available as tablets taken by mouth every 8 hours. Common side effects include headache, indigestion, and dizziness. Adempas (riociguat) can also cause severe and life-threatening harm to unborn babies, so the medication is only available to females through the Adempas REMS program.
Research prescriptions and over-the-counter medications from A to Z, compare drug prices, and start saving.